# A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia

> **NCT05171920** · PHASE2 · WITHDRAWN · sponsor: **CalciMedica, Inc.**

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Auxora
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05171920
- **Lead sponsor:** CalciMedica, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-24
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of sufficient numbers of critically ill patients to enroll the study
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05171920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05171920, "A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05171920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*